Implantable neuromodulation device targeting the vagus nerve to treat chronic inflammatory diseases, with an initial indication for rheumatoid arthritis.

Sectors
Healthcare
Life Sciences
First Invested
2020
Early
Company Status
Private
NEA Portfolio: SetPoint Medical